Getting into the brain: approaches to enhance brain drug delivery.
about
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingRegeneration strategies after the adult mammalian central nervous system injury-biomaterialsThe biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?Nanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseIntranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the artAnti-angiogenic gene therapy in the treatment of malignant gliomasPDE4 as a target for cognition enhancementBlood-CNS Barrier Impairment in ALS patients versus an animal modelNanoscale drug delivery systems and the blood-brain barrierA carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brainNon-Viral Nucleic Acid Delivery Strategies to the Central Nervous SystemExposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseasesNanoparticles for imaging and treating brain cancerTNAP and EHD1 are over-expressed in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier propertiesWnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitroVascular endothelial growth factors enhance the permeability of the mouse blood-brain barrierComprehensive analysis of the numbers, lengths and amino acid compositions of transmembrane helices in prokaryotic, eukaryotic and viral integral membrane proteins of high-resolution structure.Extravasation into brain and subsequent spread beyond the ischemic core of a magnetic resonance contrast agent following a step-down infusion protocol in acute cerebral ischemia.An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice.Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation.Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.Review of Neurosurgical Fluorescence Imaging Methodologies.Selected Gamma Aminobutyric Acid (GABA) Esters may Provide Analgesia for Some Central Pain ConditionsEpidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.Lysolipid containing liposomes for transendothelial drug deliveryMagnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system.Increased delivery of TAT across an endothelial monolayer following ischemic injury.Affinity peptide developed by phage display selection for targeting gastric cancer.Single compartment drug delivery.Inhibition of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1.Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors.Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidPeptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in ratsHendra and nipah infection: pathology, models and potential therapies.Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.Design and exploratory neuropharmacological evaluation of novel thyrotropin-releasing hormone analogs and their brain-targeting bioprecursor prodrugsDevelopment of high drug-loading nanomicelles targeting steroids to the brainExtended-release formulations of antiepileptic drugs: rationale and comparative value.
P2860
Q21223671-4405F8A4-5036-4F95-828D-80A94AE7DB12Q26752004-B3E9549A-E963-4788-99E6-C179F7EF652FQ26753140-3D50231F-483A-4E4E-81B4-02BAFDC88247Q26783306-F2FFC5FC-9356-42C6-9CDB-5AB866E5B6EBQ26830845-0C0BE000-34D5-4FAD-8CF1-0B85112E7D45Q26866276-8BFE8DBA-DFDA-4288-BBBE-D54251D6088AQ27008296-36825B3F-E7C1-4A85-9E12-861BC4DDE4A9Q27026792-DA146881-5E2D-4AB7-80CA-AE19DA7C3FAEQ27026978-B241336E-ECCB-4EEE-9E15-D8E1928D6E78Q27311201-FBA8C59D-3560-4774-B938-759A270E4F21Q28068242-33F78724-7ED4-49FB-B393-183C784EC2BFQ28382950-B677401B-2A3A-4F3B-9EA0-0FAD66F6A75AQ28394053-EBB30C9A-7D51-4261-9474-B784CEE351F9Q28484667-425928D6-5FAA-43B4-961A-461FDFE023DDQ28535094-CF682945-D5A5-4184-AE12-FA4B57DF7C46Q28539799-4C5ED563-56EE-43C6-9187-00E545695B36Q30398125-C33DC619-18EC-4226-BB4C-59F580866104Q30857036-7BE2DF95-815B-4885-B481-F892C68E9268Q33626081-FE4C7D14-32FD-4669-95D8-3720924E9150Q33776038-B741A277-9956-461B-8012-C9368872A262Q33837621-CB3EE633-5216-4286-9E32-36EEF59D6B2CQ34023717-200263B6-5387-4733-A37D-0FD6CBAC00A5Q34052708-7365A780-20D5-4E84-A815-D28CBC787988Q34203693-32856E4A-9367-4D86-A6EB-C607A6652827Q34227171-D86A327C-01FC-4FE6-9ACB-79471309C7F7Q34229309-896EE675-D1B8-41ED-BEEA-6C30E9E3AE52Q34232640-E06387DA-CD2F-4BFC-BA2C-848B6E02739EQ34259540-4942F22D-2943-4D36-AF17-93241E5B2D8CQ34263907-576B6376-0AE3-42AF-AFC7-0499420BC381Q34624551-4E304C88-BA3F-4361-A94F-14AD860720D0Q34701013-EE78A74D-0A54-490A-AD98-D8958A4F3C74Q34786475-2BAB69FE-1B7F-41AD-881D-8151521DBF79Q35189757-49535718-4AAB-4137-AE00-E8FA364BDDBFQ35658146-E62185BA-A1F7-4C7E-8F3F-D0F7CDFCFC8FQ36357995-884BCFA1-75F6-4333-9FDE-313B8D404E38Q36664277-5047A7DD-28F2-4E93-B099-816785E7F44AQ36839343-4C1A4982-47AB-4946-95C2-47447C4C9C2CQ37183468-09FC21B4-7038-47DD-9F10-4ABE9EDBF634Q37413007-F1A8E810-32DE-4B86-8A77-A010867615B5Q37423598-1AFD8B3D-2630-40D2-9FA3-6B8DB9E71162
P2860
Getting into the brain: approaches to enhance brain drug delivery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Getting into the brain: approaches to enhance brain drug delivery.
@ast
Getting into the brain: approaches to enhance brain drug delivery.
@en
Getting into the brain: approaches to enhance brain drug delivery.
@nl
type
label
Getting into the brain: approaches to enhance brain drug delivery.
@ast
Getting into the brain: approaches to enhance brain drug delivery.
@en
Getting into the brain: approaches to enhance brain drug delivery.
@nl
prefLabel
Getting into the brain: approaches to enhance brain drug delivery.
@ast
Getting into the brain: approaches to enhance brain drug delivery.
@en
Getting into the brain: approaches to enhance brain drug delivery.
@nl
P2093
P1433
P1476
Getting into the brain: approaches to enhance brain drug delivery.
@en
P2093
Avani F Amin
Bhoomika R Goyal
Jay S Bhatt
Mayur M Patel
Shraddha V Bhadada
P356
10.2165/0023210-200923010-00003
P577
2009-01-01T00:00:00Z
P6179
1023382810